RT Journal Article
SR Electronic
T1 Ready for Impact? A validity and feasibility study of instrumented mouthguards (iMGs)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.28.22270039
DO 10.1101/2022.01.28.22270039
A1 Jones, Ben
A1 Tooby, James
A1 Weaving, Dan
A1 Till, Kevin
A1 Owen, Cameron
A1 Begonia, Mark
A1 Stokes, Keith
A1 Rowson, Steve
A1 Phillips, Gemma
A1 Hendricks, Sharief
A1 Falvey, Éanna
A1 Al-Dawoud, Marwan
A1 Tierney, Gregory
YR 2022
UL http://medrxiv.org/content/early/2022/01/30/2022.01.28.22270039.abstract
AB Objectives Determine the validity and feasibility of current Instrumented mouthguards (iMGs) and associated systems.Methods Phase 1; Four iMG systems (Football Research Inc [FRI], HitIQ, ORB, Prevent) were compared against dummy headform laboratory criterion standards (25, 50, 75, 100 g). Phase 2; Four iMG systems were evaluated for on-field validity of iMG-triggered events against video-verification to determine true-positives, false-positives and false-negatives (20 ± 9 player matches per iMG). Phase 3; Four iMG systems were evaluated by eighteen rugby players, for perceptions of fit, comfort and function. Phase 4; Three iMG systems (FRI, HitIQ, Prevent) were evaluated for practical feasibility (system usability scale; SUS) by four practitioners.Results Phase 1; Total concordance correlation coefficient was 98.3%, 95.3%, 42.5% and 97.9% for FRI, HitIQ, ORB and Prevent. Phase 2; Different on-field kinematics were observed between iMGs. Positive predictive values were 0.98, 0.90, 0.53 and 0.94 for FRI, HitIQ, ORB and Prevent. Sensitivity values were 0.51, 0.40, 0.71 and 0.75 for FRI, HitIQ, ORB and Prevent. Phase 3; player perceptions of fit, comfort and function were 77%, 6/10, 55% for FRI, 88%, 8/10, 61% for HitIQ, 65%, 5/10, 43% for ORB, and 85%, 8/10, 67% for Prevent. Phase 4; SUS was 51.3-50.6/100, 71.3-78.8/100, and 83.8-80.0/100 for FRI, HitIQ, and Prevent.Conclusion This study shows that differences between current iMG systems exist. Sporting organisations can use these findings to ensure accurate head acceleration event data are obtained and system adoption is optimized, to support player welfare initiatives directly related to long-term brain health.Competing Interest StatementCompeting interests: GT, JT and DW have received Prevent Biometrics iMGs free of charge for use with Leeds Rhinos RLFC, during training and matches for a research project. BJ, MAD, KT are employed by Leeds Rhinos in a consultancy capacity. GT, JT and EF use Prevent Biometrics iMG for research projects funded by World Rugby. EF is employed by World Rugby. BJ, JT, DW, KT, CO, KS, GP, SH, MAD, GT are involved in the Rugby Football League TaCKLE (Tackle and Contact Kinematic Load & Expsoure) project. BJ and KT will be involved in the procurement of iMGs for the TaCKLE project. BJ, GP are employed in a consultancy capacity by the Rugby Football League. KS is employed by the Rugby Football Union. MB and SR lead the Virginia Tech Helmet Lab. Leeds Rhinos, World Rugby and Virginia Tech are research partners of Prevent Biometrics.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval: This project was approved by Leeds Beckett University, Local Ethics Committee (85551).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript